These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1124 related articles for article (PubMed ID: 19536010)

  • 1. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
    Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
    Lang K; Lines LM; Lee DW; Korn JR; Earle CC; Menzin J
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):198-204. PubMed ID: 18849013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer.
    Ramsey SD; Berry K; Etzioni R
    Am J Gastroenterol; 2002 Feb; 97(2):440-5. PubMed ID: 11866285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring costs: administrative claims data, clinical trials, and beyond.
    Etzioni R; Riley GF; Ramsey SD; Brown M
    Med Care; 2002 Jun; 40(6 Suppl):III63-72. PubMed ID: 12064760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administrative and claims records as sources of health care cost data.
    Riley GF
    Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National health care costs of peripheral arterial disease in the Medicare population.
    Hirsch AT; Hartman L; Town RJ; Virnig BA
    Vasc Med; 2008 Aug; 13(3):209-15. PubMed ID: 18687757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
    Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.
    Yabroff KR; Mariotto AB; Feuer E; Brown ML
    Health Econ; 2008 Aug; 17(8):947-59. PubMed ID: 17910108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estimated costs and savings of medical nutrition therapy: the Medicare population.
    Sheils JF; Rubin R; Stapleton DC
    J Am Diet Assoc; 1999 Apr; 99(4):428-35. PubMed ID: 10207394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population.
    Bhosle MJ; Reardon G; Camacho FT; Anderson RT; Balkrishnan R
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):100-11. PubMed ID: 17719512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical cost analysis: application to colorectal cancer data from the SEER Medicare database.
    Bang H
    Contemp Clin Trials; 2005 Oct; 26(5):586-97. PubMed ID: 16084777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents.
    Shugarman LR; Bird CE; Schuster CR; Lynn J
    J Womens Health (Larchmt); 2007 Mar; 16(2):214-27. PubMed ID: 17388738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of illness associated with hepatocellular carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Shah S; Thompson D
    J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.
    Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
    Am J Ophthalmol; 2010 Jul; 150(1):74-81. PubMed ID: 20493465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.